Raymond James Financial’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$795K Sell
10,963
-493,126
-98% -$35.5M ﹤0.01% 4217
2026
Q2
$35.6M Sell
504,089
-145,462
-22% -$7.85M 0.01% 1146
2026
Q1
$33.9M Sell
649,551
-97,250
-13% -$5.84M 0.01% 1116
2025
Q4
$44M Buy
746,801
+76,570
+11% +$4.65M 0.01% 892
2025
Q3
$37.3M Sell
670,231
-21,859
-3% -$1.17M 0.01% 989
2025
Q2
$35.6M Buy
692,090
+68,786
+11% +$3.46M 0.01% 969
2025
Q1
$36.5M Buy
623,304
+5,796
+0.9% +$393K 0.01% 899
2024
Q4
$44.5M Buy
+617,508
New +$45.3M 0.02% 783

Other funds holding TECH

Raymond James Financial's TECH Position: Q3 2026 in Review

Raymond James Financial reduced its Bio-Techne (TECH) stake by 98% in Q3 2026, selling an estimated $35.5M and leaving 10,963 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #4217.

Raymond James Financial first reported a position in TECH in Q4 2024 and has held it in 8 quarters since. The position peaked at $44.5M in Q4 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Raymond James Financial held 10,963 shares of Bio-Techne worth $795K as of Q3 2026.
  • Raymond James Financial sold 493,126 Bio-Techne shares in Q3 2026, an estimated $35.5M.
  • Bio-Techne made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4217 holding.
  • Raymond James Financial first reported a position in Bio-Techne in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Bio-Techne position peaked at $44.5M in Q4 2024.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.